Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Huang, Fang ^a   Tang, Linhua ^a   Yang, Henglin ^b   Zhou, Shuisen ^a   Sun, Xiaodong ^b   Liu, Hui ^b  

^a BEIJING HOSPITAL   (China)

^b Yunnan Institute of Parasitic Diseases   (China)

Author keywords

Artesunate; Molecular markers; Plasmodium falciparum

Indexed keywords

ARTEMISININ; ARTESUNATE; BIOLOGICAL MARKER; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE;

ADOLESCENT; ARTICLE; AXILLA TEMPERATURE; CHILD; CODON; DIRECTLY OBSERVED THERAPY; FEMALE; FEVER; FOLLOW UP; GENE AMPLIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; MONOTHERAPY; MULTIDRUG RESISTANCE; PARASITE; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; THERAPY; TREATMENT FAILURE; WILD TYPE;

ANTIMALARIALS; ARTEMISININS; BLOOD; CHINA; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MUTATION, MISSENSE; MYANMAR; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; TREATMENT OUTCOME;

EID: 84864928841     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-278     Document Type: Article

References (37)

1. WHO, WHO Malaria report Geneva: World Health Organization 2009
2. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 67 10.1056/NEJMoa0808859 19641202
3. WHO, Global report on antimalarial drug efficacy and drug resistance: 2000-2010 Geneva: World Health Organization 2010
4. WHO, World malaria report Geneva: World Health Organization 2010
5. Malaria situation in the Peoples Republic of China in 2010. Zhou SS, Wang Y, Li Y, Chin J Parasitol Parasit Dis 2011 29 401 403
6. WHO, Guidelines for the treatment of malaria World Health Organization 2010
7. Antimalarial drug policy in China http://www.moh.gov.cn/publicfiles/ business/htmlfiles/mohjbyfkzj/s3594/200907/41610.htm.
8. A molecular marker for chloroquine-resistant falciparum malaria. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152 (Pubitemid 32108530)
9. Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau. Ursing J, Kofoed PE, Rodrigues A, Rombo L, Gil JP, Am J Trop Med Hyg 2007 76 844 848 17488902 (Pubitemid 351627666)
10. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P, Malar J 2009 8 89 10.1186/1475-2875-8-89 19413906
11. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D, J Infect Dis 2001 183 1535 1538 10.1086/320195 11319692 (Pubitemid 32417707)
12. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Basco LK, Ringwald P, Am J Trop Med Hyg 2000 62 271 276 10813484 (Pubitemid 30257589)
13. Drug-resistant malaria-an insight. Hyde JE, FEBS J 2007 274 4688 4698 10.1111/j.1742-4658.2007.05999.x 17824955 (Pubitemid 47354145)
14. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV, J Infect Dis 2002 185 380 388 10.1086/338566 11807721 (Pubitemid 34107252)
15. Emergence of a dhfr mutation conferring highlevel drug resistance in Plasmodium falciparum populations from southwest Uganda. Lynch C, Pearce R, Pota H, Cox J, Abeku TA, Rwakimari J, Naidoo I, Tibenderana J, Roper C, J Infect Dis 2008 197 1598 1604 10.1086/587845 18471065 (Pubitemid 351706491)
16. Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar. Imwong M, Pukrittayakamee S, Pongtavornpinyo W, Nakeesathit S, Nair S, Newton P, Nosten F, Anderson TJ, Dondorp A, Day NP, White NJ, Antimicrob Agents Chemother 2008 52 2657 2659 10.1128/AAC.01459-07 18443118 (Pubitemid 351915703)
17. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, East M, Lee A, Brady L, Haynes RK, Krishna S, Nat Struct Mol Biol 2005 12 7 628 9 10.1038/nsmb947 15937493 (Pubitemid 40980816)
18. WHO, Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations Geneva: World Health Organization 2008 http://www.who.int/malaria/resistance.
19. Australian New Zealand Clinical Trials Registry https://www.anzctr.org. au.
20. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C, Antimicrob Agents Chemother 2003 47 1347 1354 10.1128/AAC.47.4.1347- 1354.2003 12654669 (Pubitemid 36368596)
21. Drug-resistance malaria: the era of ACT. Lin JT, Juliano JJ, Wongsrichanalai C, Curr Infect Dis Rep 2010 12 165 173 10.1007/s11908-010-0099-y 21308525
22. Chloroquine resistance in Plasomodium falciparum malaria parasites conferred by pfcrt mutations. Sidhu AB, Verdier-Pinard D, Fidock DA, Science 2002 298 210 213 10.1126/science.1074045 12364805
23. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC, Mol Biochem Parasitol 2000 108 13 23 10.1016/S0166-6851(00)00201-2 10802315 (Pubitemid 30236312)
24. Alteration in resistance of Plasmodium falciparum to chloroquine after cessation of chloroquine medication for twelve years. Liu DQ, Liu RJ, Ren DX, Gao DQ, Zhang CY, Qiu CP, Cai XZ, Ling CF, Liang AH, Tang Y, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1992 10 241 244 1303327
25. The point mutations in Pfcrt and Pfmdr1 genes in Plasmodium falciparum isolated from Hainan Province. Guan YY, Tang LH, Hu L, Feng XP, Liu DQ, Chin J Parasitol Parasit Dis 2005 23 135 139
26. Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province China. Yang Z, Zhang Z, Sun X, Wan W, Cui L, Trop Med Int Health 2007 12 1051 60 10.1111/j.1365-3156.2007.01882.x 17875016 (Pubitemid 47414938)
27. Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China. Zhang GQ, Guan YY, Zheng B, Wu S, Tang LH, Trop Med Int Health 2009 14 1266 71 10.1111/j.1365-3156.2009.02342.x 19772548
28. Efficiency of Pyrimethamine combined with primaquine for radical treatment of P.vivax. Zhang SX, Xinyang Medical and Health compilation 1965 2 32 unpublished data
29. Efficiency of pyrimethamine salt for P.vivax prophylaxis. Wang RZ, Railway Medicine 1981 4 246 247
30. Response of falciparum malaria to different antimalarials in Myanmar. Ejov MN, Tun T, Aung S, Sein K, Bull World Health Organ 1999 77 244 249 10212515 (Pubitemid 29282120)
31. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Triglia T, Menting JG, Wilson C, Cowman AF, Proc Natl Acad Sci 1997 94 13944 13949 10.1073/pnas.94.25.13944 9391132 (Pubitemid 28009689)
32. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O, Lancet 2005 366 1960 1963 10.1016/S0140-6736(05)67787-2 16325698 (Pubitemid 41713986)
33. New PfATP6 mutations found in Plasmodium falciparum isolates from Vietnam. Bertaux L, le Quang H, Sinou V, Thanh NX, Parzy D, Antimicrob Agents Chemother 2009 53 4570 4571 10.1128/AAC.00684-09 19687249
34. Diversity of the sarco/endoplasmic reticulum Ca2+ATPase orthologue of Plasmodium falciparum (PfATP6). Dahlström S, Veiga MI, Ferreira P, Mårtensson A, Kaneko A, Andersson B, Björkman A, Gil JP, Infect Genet Evol 2008 8 340 345 10.1016/j.meegid.2008.02.002 18359278
35. Polymorphism of PfATPase in Niger: detection of three new point mutations. Ibrahim ML, Khim N, Adam HH, Ariey F, Duchemin JB, Malar J 2009 8 28 10.1186/1475-2875-8-28 19226462
36. Detection of novel point mutations in the Plasmodium falciparum ATPase6 candidate gene for resistance to artemisinins. Menegon M, Sannella AR, Majori G, Severini C, Parasitol Int 2008 57 233 235 10.1016/j.parint.2007.12.004 18187359
37. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F, Lancet 2012 379 1960 1966 10.1016/S0140-6736(12)60484-X 22484134